ResMed Inc. RMD
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 20.05% | 0.98% | 9.23% | 13.92% | 11.94% |
| Total Depreciation and Amortization | 1.10% | -28.13% | 37.14% | 13.01% | 8.50% |
| Total Amortization of Deferred Charges | -- | -0.87% | 2.67% | -0.16% | -0.91% |
| Total Other Non-Cash Items | -230.20% | -6.04% | 19.62% | 17.92% | 30.13% |
| Change in Net Operating Assets | -156.04% | -114.24% | -61.32% | -23.85% | 142.52% |
| Cash from Operations | -7.63% | -15.62% | -4.24% | 10.08% | 40.48% |
| Capital Expenditure | -13.44% | -67.16% | -61.83% | -38.24% | -140.84% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -1,334.29% | -134.76% | -- | 100.00% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 72.08% | -120.32% | 104.63% | -45.68% | -145.49% |
| Cash from Investing | 845.66% | -186.92% | -82.56% | -38.84% | -2,550.05% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 0.00% | -- | 0.00% | -- |
| Issuance of Common Stock | -55.47% | -2.79% | -17.69% | 9.97% | -2.12% |
| Repurchase of Common Stock | -521.45% | -99.20% | -132.70% | -112.95% | -199.10% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -8.21% | -12.24% | -12.27% | -12.73% | -12.66% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -454.99% | -60.58% | -77.16% | -75.11% | -52.75% |
| Foreign Exchange rate Adjustments | 7,190.14% | -97.46% | -67.58% | 109.60% | -100.64% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -362.90% | -169.12% | -40.73% | -65.24% | -7.24% |